Regaining compliance with Nasdaq's listing requirements means that Oncocyte has met the necessary criteria to continue being listed on the exchange. This is positive news for the company as delisting can often lead to a decrease in a company's stock price. Therefore, this news could potentially lead to an increase in Oncocyte's stock price in the short term.